Smith Jason T, Sinsuebphon Nattawut, Rudkouskaya Alena, Michalet Xavier, Intes Xavier, Barroso Margarida
Center for Modeling, Simulation and Imaging in Medicine (CeMSIM), Rensselaer Polytechnic Institute, Troy, NY 12180, USA.
Present address: Elephas, 1 Erdman Pl., Madison, WI 53705, USA.
bioRxiv. 2023 Apr 22:2023.01.24.525411. doi: 10.1101/2023.01.24.525411.
Förster Resonance Energy Transfer (FRET) microscopy is used in numerous biophysical and biomedical applications to monitor inter- and intramolecular interactions and conformational changes in the 2-10 nm range. FRET is currently being extended to optical imaging, its main application being in quantifying drug-target engagement or drug release in animal models of cancer using organic dye or nanoparticle-labeled probes. Herein, we compared FRET quantification using intensity-based FRET (sensitized emission FRET analysis with the 3-cube approach using an IVIS imager) and macroscopic fluorescence lifetime (MFLI) FRET using a custom system using a time-gated ICCD, for small animal optical imaging. The analytical expressions and experimental protocols required to quantify the product of the FRET efficiency and the fraction of donor molecules involved in FRET, , are described in detail for both methodologies. Dynamic FRET quantification of transferrin receptor-transferrin binding was acquired in live intact nude mice upon intravenous injection of near infrared-labeled transferrin FRET pair and benchmarked against FRET using hybridized oligonucleotides. Even though both imaging techniques provided similar dynamic trends for receptor-ligand engagement, we demonstrate that MFLI FRET has significant advantages. Whereas the sensitized emission FRET approach using the IVIS imager required 9 measurements (6 of which are used for calibration) acquired from three mice, MFLI FRET needed only one measurement collected from a single mouse, although a control mouse might be needed in a more general situation. Based on our study, MFLI therefore represents the method of choice for longitudinal preclinical FRET studies such as that of targeted drug delivery in intact, live mice.
Förster共振能量转移(FRET)显微镜技术在众多生物物理和生物医学应用中用于监测分子间和分子内相互作用以及2-10纳米范围内的构象变化。FRET目前正被扩展到光学成像领域,其主要应用是使用有机染料或纳米颗粒标记的探针在癌症动物模型中量化药物-靶点结合或药物释放。在此,我们比较了基于强度的FRET(使用IVIS成像仪的3维立方体方法进行敏化发射FRET分析)和使用定制系统(采用时间门控ICCD)的宏观荧光寿命(MFLI)FRET用于小动物光学成像。详细描述了两种方法量化FRET效率与参与FRET的供体分子分数乘积(E\times f)所需的解析表达式和实验方案。在静脉注射近红外标记的转铁蛋白FRET对后,在活体完整裸鼠中获得了转铁蛋白受体-转铁蛋白结合的动态FRET量化,并与使用杂交寡核苷酸的FRET进行了基准比较。尽管两种成像技术在受体-配体结合方面提供了相似的动态趋势,但我们证明MFLI FRET具有显著优势。使用IVIS成像仪的敏化发射FRET方法需要从三只小鼠身上进行9次测量(其中6次用于校准),而MFLI FRET只需要从一只小鼠身上进行一次测量,不过在更一般的情况下可能需要一只对照小鼠。基于我们的研究,因此MFLI代表了纵向临床前FRET研究(如在完整的活体小鼠中进行靶向药物递送研究)的首选方法。